0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Gynaecology & obstetrics

Buy Now

Adjuvant Therapy of Breast Cancer V (Paperback, Softcover reprint of the original 1st ed. 1996) Loot Price: R2,977
Discovery Miles 29 770
Adjuvant Therapy of Breast Cancer V (Paperback, Softcover reprint of the original 1st ed. 1996): Hans-Joerg Senn, Richard D....

Adjuvant Therapy of Breast Cancer V (Paperback, Softcover reprint of the original 1st ed. 1996)

Hans-Joerg Senn, Richard D. Gelber, Aron Goldhirsch, Beat Thurlimann

Series: Recent Results in Cancer Research, 140

 (sign in to rate)
Loot Price R2,977 Discovery Miles 29 770 | Repayment Terms: R279 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

We often hear physicians, health care professionals, poli ticians, and patient advocates that "nothing has happened in the treatment of breast cancer," since patients with breast cancer, the most frequent neoplastic condition in women in industrialized countries, are continuing to suffer relapse and succumb to this dreadful disease This negativistic attitude does not seem to be justified, but, why is the transmission of clinical trial results into general practice, and with it progress, such a slow process? After many decades of frustrating stagnation of long-term survival expectations, in all stages of early, oper/lble breast cancer treated only by surgery and locoregional radio therapy, adjuvant systemic therapy (chemo- as well as endocrine treatments) clearly showed to significantly benefit in terms of disease-free and overall survival. This evolution has been extensively expounded on by the Worldwide Oxford Overview and the Expert Consensus Panel at the fourth International Conference 'on Adjuvant Therapy of Primary Breast Cancer in St. Gallen (Early Breast Cancer Trialists' Collaborative Group 1992; Glick et al. 1992). What has happened since then? During the past 3-5 years, several new concepts and treatment strategies have emerged and have been studied in various major breast cancer groups and treatment centers worldwide. Some of these can already be considered to assist in the primary treatment of operable breast cancer today, while others are . still undergoing clini, cal trials for better definition of their practical usefulness."

General

Imprint: Springer-Verlag
Country of origin: Germany
Series: Recent Results in Cancer Research, 140
Release date: December 2011
First published: 1996
Editors: Hans-Joerg Senn • Richard D. Gelber • Aron Goldhirsch • Beat Thurlimann
Dimensions: 235 x 155 x 18mm (L x W x T)
Format: Paperback
Pages: 342
Edition: Softcover reprint of the original 1st ed. 1996
ISBN-13: 978-3-642-79280-9
Categories: Books > Medicine > Clinical & internal medicine > Gynaecology & obstetrics > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-642-79280-4
Barcode: 9783642792809

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners